Skip to main content
Eutilex Co.,Ltd. logo

Eutilex Co.,Ltd. — Investor Relations & Filings

Ticker · 263050 ISIN · KR7263050007 KO Manufacturing
Filings indexed 410 across all filing types
Latest filing 2026-02-13 Audit Report / Informat…
Country KR South Korea
Listing KO 263050

About Eutilex Co.,Ltd.

https://www.eutilex.com/en/

Eutilex Co., Ltd. is a biotechnology company focused on the research and development of immunotherapeutics for cancers and autoimmune diseases. The company's core approach involves selecting targets that enhance or suppress human immune responses. Its pipeline is centered on three primary technology platforms: T-cell therapy, antibody therapy, and CAR-T cell therapy. Key development programs include adoptive T-cell therapies, such as those based on 4-1BB cytotoxic T lymphocytes (CTL), and various immunomodulatory antibody therapeutics designed to treat a range of incurable diseases.

Recent filings

Filing Released Lang Actions
내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생
Audit Report / Information Classification · 95% confidence The document is a regulatory filing from a Korean company (Eutilex) regarding the 'occurrence of grounds for designation as an administrative issue, formal delisting, and substantive review of listing eligibility' based on internal financial statements. This is a mandatory disclosure of financial status and regulatory triggers, which falls under the category of general regulatory announcements for filings that do not fit into specific report types like 10-K or ER. FY 2025
2026-02-13 Korean
기타시장안내(관리종목지정우려종목)
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice from the Korea Exchange regarding Eutilex. It informs the market about the potential designation of the company as an 'administrative issue' (management stock) due to recurring losses exceeding 50% of equity. Since this is a regulatory announcement regarding market status and compliance rather than a financial report, M&A, or dividend notice, it falls under the general regulatory filing category.
2026-02-13 Korean
기타시장안내 (상장적격성 실질심사 대상결정 기한 안내)
Regulatory Filings Classification · 95% confidence The document is a short notice from the stock exchange regarding the timeline for a 'listing eligibility review' (상장적격성 실질심사) for Eutilex. It is a regulatory announcement concerning the status of the company's listing and does not fit into specific categories like financial reports or M&A. Therefore, it is classified as a general regulatory filing.
2026-02-09 Korean
불성실공시법인지정 (공시번복 1건, 공시불이행 3건)
Regulatory Filings Classification · 95% confidence The document is a formal regulatory notice from the KOSDAQ market regarding the designation of Eutilex as an 'unfaithful disclosure corporation' due to disclosure violations (delays and reversals). It details the specific violations, penalty points, and regulatory consequences (such as the initiation of a listing eligibility review). This falls under regulatory announcements regarding compliance and legal/regulatory status, which is best classified as a Regulatory Filing (RNS) as it does not fit into specific categories like M&A, dividends, or financial reports.
2026-02-06 Korean
주권매매거래정지 (상장적격성 실질심사 대상 (사유발생))
Delisting Announcement Classification · 95% confidence The document is a short, formal notice regarding the suspension of stock trading ('주권매매거래정지') for Eutilex due to a listing eligibility review ('상장적격성 실질심사'). This is a regulatory announcement concerning exchange status and does not fit into specific categories like earnings, dividends, or management changes. Therefore, it falls under the fallback category for regulatory announcements.
2026-02-06 Korean
기타시장안내 (상장적격성 실질심사관련안내)
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice from the KOSDAQ exchange regarding Eutilex Co., Ltd. It informs the market about the initiation of a 'listing eligibility review' (상장적격성 실질심사) due to the accumulation of penalty points for non-compliant disclosures. As this is a regulatory announcement regarding a company's listing status and compliance, it fits best under the general regulatory filings category.
2026-02-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.